A possible divestiture of Bayer AG's (OTCPK:BAYZF) consumer health business would likely cause a massive tax bill. Bayer (OTCPK:BAYZF) has hired several teams of bankers to study various breakup scenarios for the German conglomerate, according to a on Monday, which cited people familiar with the matter. The conclusion from the analysis is that any breakup may be very difficult.